Adapting human pluripotent stem cells to high-throughput and high-content screening

Nature Protocols

Volumn 8, Issue 1, 2013, Pages 111-130

  Desbordes, Sabrina C ^a,b   Studer, Lorenz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CELL ASSAY; CELL DIFFERENTIATION; CELL RENEWAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL EXPANSION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KARYOTYPING; LAMININ; MICE; PLURIPOTENT STEM CELLS; PROTEOGLYCANS; SMALL MOLECULE LIBRARIES;

EID: 84872013374     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2012.139     Document Type: Article

References (79)

1. Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
2. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A. & Bongso, A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18, 399-404 (2000). (Pubitemid 30217526)
3. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
4. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
5. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
6. Park, I.H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
7. Lowry, W.E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105, 2883-2888 (2008). (Pubitemid 351723638)
8. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276-1284 (2008).
9. Jensen, J., Hyllner, J. & Bjorquist, P. Human embryonic stem cell technologies and drug discovery. J. Cell Physiol. 219, 513-519 (2009).
10. Eglen, R. & Reisine, T. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening. Assay Drug Dev. Technol. 9, 108-124 (2011).
11. Dimos, J.T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221 (2008).
12. Abeliovich, A. & Doege, C.A. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron 61, 337-339 (2009).
13. Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856-5861 (2008). (Pubitemid 351758462)
14. Raya, A. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59 (2009).
15. Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406 (2009).
16. Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229 (2011).
17. Liu, G.H. et al. Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688-694 (2011).
18. Batista, L.F. et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399-402 (2011).
19. Brennand, K.J. et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473, 221-225 (2011).
20. Nguyen, H.N., Byers, B. & Cord, B. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267-280 (2011).
21. Boyer, L.A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005). (Pubitemid 41345211)
22. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008). (Pubitemid 351253686)
23. Jiang, J. & Ng, H.H. TGF-β and SMADs talk to NANOG in human embryonic stem cells. Cell Stem Cell 3, 127-128 (2008).
24. Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J.A. & Kosik, K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647-658 (2009).
25. Hoffman, L.M. & Carpenter, M.K. Characterization and culture of human embryonic stem cells. Nat. Biotechnol. 23, 699-708 (2005). (Pubitemid 41716360)
26. Ludwig, T.E. et al. Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637-646 (2006). (Pubitemid 44123431)
27. Bendall, S.C. et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015-1021 (2007). (Pubitemid 47345578)
28. Hasegawa, K., Fujioka, T., Nakamura, Y., Nakatsuji, N. & Suemori, H. A method for the selection of human embryonic stem cell sublines with high replating efficiency after single-cell dissociation. Stem Cells 24, 2649-2660 (2006). (Pubitemid 46053003)
29. Bajpai, R., Lesperance, J., Kim, M. & Terskikh, A.V. Efficient propagation of single cells Accutase-dissociated human embryonic stem cells. Mol. Reprod. Dev. 75, 818-827 (2008). (Pubitemid 351438945)
30. Ellerstrom, C., Strehl, R., Noaksson, K., Hyllner, J. & Semb, H. Facilitated expansion of human embryonic stem cells by single-cell enzymatic dissociation. Stem Cells 25, 1690-1696 (2007). (Pubitemid 47121846)
31. Baker, D.E. et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat. Biotechnol. 25, 207-215 (2007). (Pubitemid 46227120)
32. Watanabe, K. et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686 (2007). (Pubitemid 46897207)
33. Phillips, B.W. et al. Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol. 138, 24-32 (2008).
34. Lock, L.T. & Tzanakakis, E.S. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng. Part A 15, 2051-2063 (2009).
35. Nie, Y., Bergendahl, V., Hei, D.J., Jones, J.M. & Palecek, S.P. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol. Prog. 25, 20-31 (2009).
36. Oh, S.K. et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2, 219-230 (2009).
37. Thomas, R.J. et al. Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol. Bioeng. 102, 1636-1644 (2009).
38. Serra, M. et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J. Biotechnol. 148, 208-215 (2010).
39. Fernandes, A.M. et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz. J. Med. Biol. Res. 42, 515-522 (2009).
40. Steiner, D. et al. Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension. Nat. Biotechnol. 28, 361-364 (2010).
41. Joannides, A. et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24, 230-235 (2006). (Pubitemid 44464790)
42. Terstegge, S. et al. Automated maintenance of embryonic stem cell cultures. Biotechnol. Bioeng. 96, 195-201 (2007). (Pubitemid 46036171)
43. Melkoumian, Z. et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat. Biotechnol. 28, 606-610 (2010).
44. Rodin, S. et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol. 28, 611-615 (2010).
45. Villa-Diaz, L.G. et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat. Biotechnol. 28, 581-583 (2010).
46. Amit, M. et al. Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells. Nat. Protoc. 6, 572-579 (2010).
47. Olmer, R. et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 5, 51-64 (2010).
48. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A. & Martin, U. Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6, 689-700 (2011).
49. Firestone, A.J. & Chen, J.K. Controlling destiny through chemistry: small-molecule regulators of cell fate. ACS Chem. Biol. 5, 15-34 (2010).
50. Kochegarov, A. Small molecules for stem cells. Expert Opin. Ther. Pat. 19, 275-281 (2009).
51. Li, W. & Ding, S. Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol. Sci. 31, 36-45 (2010).
52. Desbordes, S.C. et al. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2, 602-612 (2008). (Pubitemid 351729221)
53. Borowiak, M. et al. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 4, 348-358 (2009).
54. Chen, S. et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat. Chem. Biol. 5, 258-265 (2009).
55. Zhu, S. et al. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell 4, 416-426 (2009).
56. Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275-280 (2009).
57. Han, Y. et al. Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS ONE 4, e7155 (2009).
58. Mayr, L.M. & Fuerst, P. The future of high-throughput screening. J. Biomol. Screen 13, 443-448 (2008). (Pubitemid 351905082)
59. Zanella, F., Lorens, J.B. & Link, W. High content screening: seeing is believing. Trends Biotechnol. 28, 237-245 (2010).
60. Bickle, M. The beautiful cell: high-content screening in drug discovery. Anal. Bioanal. Chem. 398, 219-226 (2010).
61. Phillips, B.W. & Crook, J.M. Pluripotent human stem cells: a novel tool in drug discovery. BioDrugs 24, 99-108 (2010).
62. Ebert, A.D. & Svendsen, C.N. Human stem cells and drug screening: opportunities and challenges. Nat. Rev. Drug Discov. 9, 367-372 (2010).
63. Phillips, B.W. et al. Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells Dev 16, 561-578 (2007). (Pubitemid 47378729)
64. Perrier, A.L. et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad Sci. USA 101, 12543-12548 (2004). (Pubitemid 39122060)
65. Spence, J.R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105-109 (2010).
66. Spielmann, H. et al. The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57). Altern. Lab. Anim. 34, 527-538 (2006).
67. Adler, S., Pellizzer, C., Hareng, L., Hartung, T. & Bremer, S. First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicol. In Vitro 22, 200-211 (2008). (Pubitemid 350267101)
68. Paquette, J.A. et al. Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry. Birth Defects Res. B Dev. Reprod. Toxicol. 83, 104-111 (2008). (Pubitemid 351631344)
69. Andrews, P.D. et al. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochem. J. 432, 21-33 (2010).
70. Barbaric, I. et al. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem Cell Res. 5, 104-119 (2010).
71. Xu, Y. et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc. Natl. Acad. Sci. USA 107, 8129-8134 (2010).
72. Damoiseaux, R., Sherman, S.P., Alva, J.A., Peterson, C. & Pyle, A.D. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 27, 533-542 (2009).
73. Chia, N.Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468, 316-320 (2010).
74. Padilla-Nash, H.M., Barenboim-Stapleton, L., Difilippantonio, M.J. & Ried, T. Spectral karyotyping analysis of human and mouse chromosomes. Nat. Protoc. 1, 3129-3142 (2006).
75. Placantonakis, D.G. et al. BAC transgenesis in human embryonic stem cells as a novel tool to define the human neural lineage. Stem Cells 27, 521-532 (2009).
76. Antczak, C. et al. High-throughput identification of inhibitors of human mitochondrial peptide deformylase. J. Biomol. Screen 12, 521-535 (2007). (Pubitemid 46871829)
77. Malo, N., Hanley, J.A., Cerquozzi, S., Pelletier, J. & Nadon, R. Statistical practice in high-throughput screening data analysis. Nat. Biotechnol. 24, 167-175 (2006). (Pubitemid 43221699)
78. Malo, N. et al. Experimental design and statistical methods for improved hit detection in high-throughput screening. J. Biomol. Screen 15, 990-1000 (2010).
79. Ramadan, N., Flockhart, I., Booker, M., Perrimon, N. & Mathey-Prevot, B. Design and implementation of high-throughput RNAi screens in cultured Drosophila cells. Nat. Protoc. 2, 2245-2264 (2007). (Pubitemid 351565864)